# Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

> **NCT01135537** · PHASE2 · TERMINATED · sponsor: **The Hospital for Sick Children** · enrollment: 30 (actual)

## Conditions studied

- Malignancy
- Metabolic Disease
- Genetic Disorder

## Interventions

- **BIOLOGICAL:** Thymoglobulin (rATG)

## Key facts

- **NCT ID:** NCT01135537
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** The study was closed before 2017 due to inconclusive results from Lab
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135537, "Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01135537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*